Skip to main content

Table 2 Acutely ill COVID-19 inpatient demographics and clinical data

From: Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism

Variable

Ward inpatients (n = 23)

ICU inpatients (n = 23)

Age (yrs), median (IQR)

60.0 (20.0)

60.0 (17.0)

Male sex, no. (%)

13 (56.5)

13 (56.5)

Weight (kg), median (IQR)

86.0 (13.4)

89.8 (26.5)

Height (cm), median (IQR)

170.0 (8.0)

171.0 (8.5)

BMI, median (IQR)

28.1 (5.4)

30.3 (7.1)

MODS, median (IQR)

–

5.0 (1.8)

SOFA score, median (IQR)

–

6.0 (5.5)

Comorbidities, no. (%)

  

 Diabetes

4 (17.4)

10 (43.5)

 Hypertension

9 (39.1)

10 (43.5)

 Coronary artery/heart disease

1 (4.3)

2 (8.7)

 Chronic/congestive heart failure

0 (0.0)

0 (0.0)

 Chronic kidney disease

1 (4.3)

2 (8.7)

 Cancer

3 (13.0)

2 (8.7)

 COPD

0 (0.0)

1 (4.3)

Presenting symptoms, no. (%)

  

 Fever

18 (78.3)

–

 Cough

19 (82.6)

–

 Anosmia/ageusia

5 (21.7)

–

 Pharyngitis

5 (21.7)

–

 Headache

3 (13.0)

–

 Myalgias

14 (60.9)

–

 Dyspnea

20 (87.0)

–

 Chest pain

3 (13.0)

–

 Nausea/vomiting/diarrhea

10 (43.5)

–

Pulmonary pathology, no. (%)

  

 Unilateral pneumonia

–

1 (4.3)

 Bilateral pneumonia

22 (95.7)

21 (91.3)

 Interstitial infiltrates/R effusion

–

1 (4.3)

Laboratories, median (IQR)

  

 Hemoglobin

130.0 (24.0)

119.0 (28.5)

 White blood cell count

7.0 (5.0)

8.8 (7.5)

 Neutrophils

5.9 (4.2)

7.6 (6.9)

 Lymphocytes

0.8 (0.6)

0.7 (0.6)

 Platelets

219.0 (80.5)

216.0 (131.0)

 Creatinine

70.0 (28.5)

81.0 (113.5)

 International normalized ratio

1.1 (0.1)

1.2 (0.1)

 Lactate

1.7 (1.0)

1.3 (0.8)

 Partial thromboplastin time (PTT)

–

27.0 (5.0)

 PaO2/FiO2 Ratio

–

128.0 (70.0)

Interventions, no. (%)

  

 Renal replacement therapy

0 (0.0)

6 (26.1)

 High-flow nasal cannula

13 (56.5)

15 (65.2)

 Non-invasive mechanical ventilation

1 (4.3)

7 (30.4)

 Invasive mechanical ventilation

2 (8.7)

21 (91.3)

 Extracorporeal membrane oxygenation

0 (0.0)

1 (4.3)

 Tocilizumab

2 (8.7)

0 (0.0)

 Steroids

22 (95.7)

15 (65.2)

 Vasoactive medications

2 (9.5)

19 (82.6)

 Antibiotics

22 (95.7)

23 (100.0)

 Anti-virals

5 (21.7)

3 (13.0)

 Antiplatelet

4 (17.4)

18 (78.3)

 Anticoagulation

23 (100.0)

22 (95.6)

Outcomes

  

 Days, median (IQR)

8.0 (7.0)

15.0 (14.0)

 Died, no. (%)

2 (8.7)

11 (47.8)